Real-time enrollment status for this autosomal dominant polycystic kidney disease clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 11:08 AM UTC
| NCT Number | NCT07228364 |
| Recruiting Status | Recruiting |
| Condition | Autosomal Dominant Polycystic Kidney Disease |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 8 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 28, 2026 (Jul 28, 2026) |
As of August 30, 2026: Clinical trial NCT07228364 is currently recruiting participants. This phase1 study for autosomal dominant polycystic kidney disease is actively seeking new participants at 8 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07228364 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07228364 was last updated Jul 28, 2026 (July 28, 2026). HelloStudys verifies this status automatically.